2. GPCR/G Protein Neuronal Signaling
  3. 5-HT Receptor
  4. 2709045-53-2

2709045-53-2

AKT-IN-9 Chemical Structure

2709045-53-2

Chemical Structure

  • AKT-IN-9
  • CAS No: 2709045-53-2
    Formula: C24H29ClN6O
    Molecular Weight: 452.98
  • IUPAC Name: (2S)-1-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)-2-(4-chlorophenyl)-3-(isopropylamino)propan-1-one
  • InChIKey: IEBRWVGSCWRBGP-GZNCHQMQSA-N
  • SMILES: CC(C)NC[C@H](C1=CC=C(C=C1)Cl)C(N2C3CN(C4=C5C(NC=C5)=NC=N4)CC2CC3)=O

Biological Activity: AKT-IN-9 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-9 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 1)[1].

Cat. No. Product Name Purity Description
HY-144059 AKT-IN-9 AKT-IN-9 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-9 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 1).

References

[1]. Xin Li, et al. Thickened dicyclic derivatives, their preparation methods and their application in medicine. Patent WO2021185238A1.

Keywords:

AKT-IN-9